1904 related articles for article (PubMed ID: 7907615)
1. Prognostic significance of PCNA grade in malignant melanoma.
Woosley JT; Dietrich DR
J Cutan Pathol; 1993 Dec; 20(6):498-503. PubMed ID: 7907615
[TBL] [Abstract][Full Text] [Related]
2. Prognostic evaluation of cutaneous malignant melanoma: a clinicopathologic and immunohistochemical study.
Niezabitowski A; Czajecki K; Ryś J; Kruczak A; Gruchała A; Wasilewska A; Lackowska B; Sokołowski A; Szklarski W
J Surg Oncol; 1999 Mar; 70(3):150-60. PubMed ID: 10102344
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of proliferating cell nuclear antigen, bromodeoxyuridine, and mitotic index in uveal melanoma.
Ghazvini S; Kroll S; Char DH; Frigillana H
Invest Ophthalmol Vis Sci; 1995 Dec; 36(13):2762-7. PubMed ID: 7499099
[TBL] [Abstract][Full Text] [Related]
4. Morphometric, DNA, and proliferating cell nuclear antigen measurements in benign melanocytic lesions and cutaneous malignant melanoma.
Björnhagen V; Bonfoco E; Brahme EM; Lindholm J; Auer G
Am J Dermatopathol; 1994 Dec; 16(6):615-23. PubMed ID: 7864299
[TBL] [Abstract][Full Text] [Related]
5. [The relationship between Fas/FasL and proliferating cell nuclear antigen expression and malignant degree in human melanoma].
Wang YC; Tan Y
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):965-8. PubMed ID: 18756968
[TBL] [Abstract][Full Text] [Related]
6. Determination of proliferating fractions in malignant melanomas by anti-PCNA/cyclin monoclonal antibody.
Takahashi H; Strutton GM; Parsons PG
Histopathology; 1991 Mar; 18(3):221-7. PubMed ID: 1675189
[TBL] [Abstract][Full Text] [Related]
7. Fas-mediated apoptosis of melanoma cells and infiltrating lymphocytes in human malignant melanomas.
Shukuwa T; Katayama I; Koji T
Mod Pathol; 2002 Apr; 15(4):387-96. PubMed ID: 11950912
[TBL] [Abstract][Full Text] [Related]
8. [Proliferating cell nuclear antigen (PCNA/cyclin) in gastric carcinoma in relation to its prognosis].
Li N
Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):34-6. PubMed ID: 8101481
[TBL] [Abstract][Full Text] [Related]
9. Comparison of proliferative activity as assessed by proliferating cell nuclear antigen (PCNA) and Ki-67 monoclonal antibodies in melanocytic skin lesions. A quantitative immunohistochemical study.
Rieger E; Hofmann-Wellenhof R; Soyer HP; Kofler R; Cerroni L; Smolle J; Kerl H
J Cutan Pathol; 1993 Jun; 20(3):229-36. PubMed ID: 8103531
[TBL] [Abstract][Full Text] [Related]
10. Proliferating cell nuclear antigen in hepatocellular carcinoma and small cell liver dysplasia.
Adachi E; Hashimoto H; Tsuneyoshi M
Cancer; 1993 Nov; 72(10):2902-9. PubMed ID: 8106139
[TBL] [Abstract][Full Text] [Related]
11. A comparative assessment of proliferating cell nuclear antigen, c-myc p62, and nucleolar organizer region staining in non-Hodgkin's lymphomas: a histochemical and immunohistochemical study of 200 cases.
Korkolopoulou P; Patsouris E; Pangalis G; Tsenga A; Elemenoglou J; Thomas-Tsangli E; Spandidos D; Kittas C
Hum Pathol; 1993 Apr; 24(4):371-7. PubMed ID: 7684020
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical study of Spitz nevi and malignant melanoma with use of antibody to proliferating cell nuclear antigen.
Niemann TH; Argenyi ZB
Am J Dermatopathol; 1993 Oct; 15(5):441-5. PubMed ID: 7902020
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of proliferating cell nuclear antigen-positive growth fraction in gastric adenomas.
Kim WH; Choe GY; Kim YI
J Korean Med Sci; 1992 Sep; 7(3):199-203. PubMed ID: 1363046
[TBL] [Abstract][Full Text] [Related]
14. Proliferative activity of cutaneous melanocytic neoplasms defined by a proliferating cell nuclear antigen labelling index.
Tokuda Y; Mukai K; Matsuno Y; Furuya S; Shimosato Y; Takasaki Y; Saida T; Ishihara K
Arch Dermatol Res; 1992; 284(6):319-23. PubMed ID: 1363460
[TBL] [Abstract][Full Text] [Related]
15. Cytomorphological variations, proliferation and angiogenesis in the prognosis of cutaneous melanoma.
Jonjic N; Zamolo G; Stifter S; Fuckar D; Gruber F; Sasso F; Rizzardi C; Melato M
Clin Exp Dermatol; 2003 May; 28(3):310-4. PubMed ID: 12780721
[TBL] [Abstract][Full Text] [Related]
16. Proliferating cell nuclear antigen distribution in keratoacanthoma and squamous cell carcinoma.
Phillips P; Helm KF
J Cutan Pathol; 1993 Oct; 20(5):424-8. PubMed ID: 7507945
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of ploidy and proliferation markers in renal cell carcinoma.
Tannapfel A; Hahn HA; Katalinic A; Fietkau RJ; Kühn R; Wittekind CW
Cancer; 1996 Jan; 77(1):164-71. PubMed ID: 8630925
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M
Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190
[TBL] [Abstract][Full Text] [Related]
19. Poor prognostic value of proliferating cell nuclear antigen labelling index in breast carcinoma.
Thomas M; Noguchi M; Kitagawa H; Kinoshita K; Miyazaki I
J Clin Pathol; 1993 Jun; 46(6):525-8. PubMed ID: 8101192
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinoma breast.
Aziz SA; Pervez S; Khan SM; Kayani N; Nasir MI
J Coll Physicians Surg Pak; 2005 Apr; 15(4):225-9. PubMed ID: 15857596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
